ADIL vs NXPI · $6.0M cap vs P/E 29, rev $12.27B
Adial Pharmaceuticals Inc (ADIL) versus NXP Semiconductors NV (NXPI) — a side-by-side from cached financials, not a winner call.
Adial Pharmaceuticals Inc (ADIL) is a biotechnology company listed on NASDAQ.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
ADIL does not have a complete income-statement cache yet.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
ADIL currently screens at market cap $6.0M. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Not investment advice. Open the ADIL and NXPI stock pages for the full models.
Not investment advice.